Cerebrospinal fluid macrophage biomarkers in amyotrophic lateral sclerosis
AG Thompson, E Gray, ML Thézénas… - Annals of …, 2018 - Wiley Online Library
Objective The neurodegenerative disease, amyotrophic lateral sclerosis (ALS), is a
heterogeneous clinical syndrome involving multiple molecular pathways. The development …
heterogeneous clinical syndrome involving multiple molecular pathways. The development …
Cerebrospinal fluid macrophage biomarkers in amyotrophic lateral sclerosis
AG Thompson, E Gray, ML Thézénas… - Annals of …, 2018 - pubmed.ncbi.nlm.nih.gov
Objective The neurodegenerative disease, amyotrophic lateral sclerosis (ALS), is a
heterogeneous clinical syndrome involving multiple molecular pathways. The development …
heterogeneous clinical syndrome involving multiple molecular pathways. The development …
[引用][C] Cerebrospinal fluid macrophage biomarkers in amyotrophic lateral sclerosis
AG Thompson, E Gray, ML Thézénas, PD Charles… - Annals of …, 2018 - cir.nii.ac.jp
Cerebrospinal fluid macrophage biomarkers in amyotrophic lateral sclerosis | CiNii Research
CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ] 論文・データをさがす 大学図書館の本を …
CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ] 論文・データをさがす 大学図書館の本を …
Cerebrospinal fluid macrophage biomarkers in amyotrophic lateral sclerosis.
AG Thompson, E Gray, ML Thézénas… - Annals of …, 2018 - europepmc.org
Objective The neurodegenerative disease, amyotrophic lateral sclerosis (ALS), is a
heterogeneous clinical syndrome involving multiple molecular pathways. The development …
heterogeneous clinical syndrome involving multiple molecular pathways. The development …
[PDF][PDF] Cerebrospinal Fluid Macrophage Biomarkers in Amyotrophic Lateral Sclerosis
ML Thézénas, PD Charles, S Evetts, MT Hu… - ANN …, 2018 - scholar.archive.org
Objective: The neurodegenerative disease, amyotrophic lateral sclerosis (ALS), is a
heterogeneous clinical syndrome involving multiple molecular pathways. The development …
heterogeneous clinical syndrome involving multiple molecular pathways. The development …
Cerebrospinal fluid macrophage biomarkers in amyotrophic lateral sclerosis
A Thompson, E Gray, M Thézénas, P Charles… - Annals of …, 2018 - ora.ox.ac.uk
Objective: The neurodegenerative disease amyotrophic lateral sclerosis (ALS) is a
heterogeneous clinical syndrome involving multiple molecular pathways. The development …
heterogeneous clinical syndrome involving multiple molecular pathways. The development …